+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Brachytherapy Market by Indication, Offering, Dosage Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011097
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Brachytherapy Market grew from USD 962.01 million in 2023 to USD 1.01 billion in 2024. It is expected to continue growing at a CAGR of 5.75%, reaching USD 1.42 billion by 2030.

Brachytherapy is a form of internal radiation treatment wherein radioactive sources are placed in close proximity to the area requiring therapy, most commonly used to treat cancers such as prostate, cervical, and breast cancers. This precise targeting minimizes exposure to surrounding healthy tissues, thereby reducing side effects compared to external beam radiation therapy. The necessity for brachytherapy arises from its effectiveness in delivering high doses of radiation directly to the tumor while sparing healthy tissues, which is crucial for cancers that are localized and can be targeted directly. The application scope of brachytherapy includes not only traditional cancer treatments but also emerging areas like ocular and skin cancers, demonstrating its expanding versatility. End-use sectors include hospitals, oncology centers, and specialty clinics, with a notable increase in outpatient capabilities due to advancements in the technology.

Key market growth factors include the rising prevalence of cancer, technological advancements enhancing procedural efficacy, and increasing awareness of treatment options. The demand is further fueled by favorable reimbursement scenarios and government initiatives promoting advanced cancer care. Latest potential opportunities lie in the development of next-generation radioactive isotopes and automation in treatment planning and delivery. However, the market faces challenges such as a high cost of treatment, regulatory complexities, and a shortage of skilled healthcare professionals trained in brachytherapy.

Innovation opportunities are abundant in enhancing imaging technologies for better placement of radioactive sources and in integrating artificial intelligence to optimize treatment plans. Business growth can also benefit from partnerships with academic and research institutions to drive clinical trials and validate new technologies. The brachytherapy market is characterized by steady growth with a high degree of competition, primarily due to the entry of new market players and continuous technological advancements. Companies should focus on emerging markets with unmet medical needs and invest in educational programs to address the shortage of skilled professionals, enhancing both market penetration and service quality.

Understanding Market Dynamics in the Brachytherapy Market

The Brachytherapy Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of cancer worldwide and need for efficient treatment
    • Inclination toward early diagnosis and treatment of diseases
    • Increasing preference for minimally invasive medical procedures
  • Market Restraints
    • High cost and complexity in brachytherapy
  • Market Opportunities
    • Utilization of personalized medicine approach to deliver precise treatment
    • Ongoing R&D to enhance the efficacy of brachytherapy
  • Market Challenges
    • Stringent regulatory framework and dearth of skilled professionals

Exploring Porter’s Five Forces for the Brachytherapy Market

Porter’s Five Forces framework further strengthens the insights of the Brachytherapy Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Brachytherapy Market

External macro-environmental factors deeply influence the performance of the Brachytherapy Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Brachytherapy Market

The Brachytherapy Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Brachytherapy Market

The Brachytherapy Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Brachytherapy Market

The Brachytherapy Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brachytherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, BEBIG Medical GmbH, Becton, Dickinson and Company, Best Medical International, Inc., BWX Technologies. Inc., CivaTech Oncology Inc., CIVCO Medical Solutions, Eckert & Ziegler Radiopharma GmbH, Elekta AB, GammaTile, Healvita Group GmbH, Hologic, Inc., iCAD, Inc., IsoAid, LLC, Isoray Medical, Inc. by Perspective Therapeutics, Mick Radio-Nuclear Instruments, Inc., Mirion Technologies, Inc., Nihon Medi-Physics Co., Ltd., Qfix, Theragenics, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Brachytherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Indication
    • Breast Cancer
    • Gynecological Cancer
    • Prostate Cancer
  • Offering
    • Devices
      • Afterloaders
      • Applicators
      • Seeds
    • Services
  • Dosage Type
    • High-Dose Rate (HDR) Brachytherapy
    • Low-Dose Rate (LDR) Brachytherapy
  • End User
    • Hospitals
    • Specialty Clinic
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cancer worldwide and need for efficient treatment
5.1.1.2. Inclination toward early diagnosis and treatment of diseases
5.1.1.3. Increasing preference for minimally invasive medical procedures
5.1.2. Restraints
5.1.2.1. High cost and complexity in brachytherapy
5.1.3. Opportunities
5.1.3.1. Utilization of personalized medicine approach to deliver precise treatment
5.1.3.2. Ongoing R&D to enhance the efficacy of brachytherapy
5.1.4. Challenges
5.1.4.1. Stringent regulatory framework and dearth of skilled professionals
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Brachytherapy Market, by Indication
6.1. Introduction
6.2. Breast Cancer
6.3. Gynecological Cancer
6.4. Prostate Cancer
7. Brachytherapy Market, by Offering
7.1. Introduction
7.2. Devices
7.2.1. Afterloaders
7.2.2. Applicators
7.2.3. Seeds
7.3. Services
8. Brachytherapy Market, by Dosage Type
8.1. Introduction
8.2. High-Dose Rate (HDR) Brachytherapy
8.3. Low-Dose Rate (LDR) Brachytherapy
9. Brachytherapy Market, by End User
9.1. Introduction
9.2. Hospitals
9.3. Specialty Clinic
10. Americas Brachytherapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Brachytherapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Brachytherapy Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BRACHYTHERAPY MARKET RESEARCH PROCESS
FIGURE 2. BRACHYTHERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BRACHYTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BRACHYTHERAPY MARKET DYNAMICS
TABLE 7. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRACHYTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRACHYTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HIGH-DOSE RATE (HDR) BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRACHYTHERAPY MARKET SIZE, BY LOW-DOSE RATE (LDR) BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. CANADA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 42. CANADA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 43. CANADA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. MEXICO BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 47. MEXICO BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 48. MEXICO BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. CHINA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. CHINA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 69. CHINA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 70. CHINA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 71. CHINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. INDIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. INDIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 74. INDIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 75. INDIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 76. INDIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. JAPAN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. JAPAN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 84. JAPAN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 85. JAPAN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 86. JAPAN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. THAILAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. THAILAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 114. THAILAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 115. THAILAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 116. THAILAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. DENMARK BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. DENMARK BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 130. DENMARK BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 131. DENMARK BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. EGYPT BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. EGYPT BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 135. EGYPT BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 136. EGYPT BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. FINLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. FINLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 140. FINLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 141. FINLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 142. FINLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. FRANCE BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 145. FRANCE BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 146. FRANCE BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. GERMANY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. GERMANY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 150. GERMANY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 151. GERMANY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. ITALY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 160. ITALY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 161. ITALY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 162. ITALY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. NORWAY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. NORWAY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 175. NORWAY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 176. NORWAY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 177. NORWAY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. POLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. POLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 180. POLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 181. POLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 182. POLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. QATAR BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 185. QATAR BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 186. QATAR BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SPAIN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. SPAIN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 205. SPAIN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 206. SPAIN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. TURKEY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. TURKEY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 220. TURKEY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 221. TURKEY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 234. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Brachytherapy market, which are profiled in this report, include:
  • Accuray Incorporated
  • BEBIG Medical GmbH
  • Becton, Dickinson and Company
  • Best Medical International, Inc.
  • BWX Technologies. Inc.
  • CivaTech Oncology Inc.
  • CIVCO Medical Solutions
  • Eckert & Ziegler Radiopharma GmbH
  • Elekta AB
  • GammaTile
  • Healvita Group GmbH
  • Hologic, Inc.
  • iCAD, Inc.
  • IsoAid, LLC
  • Isoray Medical, Inc. by Perspective Therapeutics
  • Mick Radio-Nuclear Instruments, Inc.
  • Mirion Technologies, Inc.
  • Nihon Medi-Physics Co., Ltd.
  • Qfix
  • Theragenics
  • Varian Medical Systems, Inc.

Methodology

Loading
LOADING...

Table Information